Inventor
HINMAN ANDREW W
US22 patents
⚠️ This page may combine multiple inventors who share the name “HINMAN ANDREW W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
7 patentsUS10703701B2Jul 7, 2020
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
PTC THERAPEUTICS INC7 citations81
US11174212B2Nov 16, 2021
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC5 citations79
US10981855B2Apr 20, 2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
PTC THERAPEUTICS INC2 citations70
US11667596B2Jun 6, 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC1 citations68
US11312697B2Apr 26, 2022
Process for the production of alpha-tocotrienol and derivatives
PTC THERAPEUTICS INC0 citations62
US11680034B2Jun 20, 2023
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
PTC THERAPEUTICS INC0 citations60
US11746077B2Sep 5, 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC0 citations58
EDISON PHARMACEUTICALS INC
5 patentsUS9486435B2Nov 8, 2016
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC7 citations84
US9296712B2Mar 29, 2016
Resorufin derivatives for treatment of oxidative stress disorders
EDISON PHARMACEUTICALS INC12 citations82
US9629815B2Apr 25, 2017
Benzoquinone derivatives for treating oxidative stress disorders
EDISON PHARMACEUTICALS INC5 citations72
US9073873B2Jul 7, 2015
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC4 citations72
US9090576B2Jul 28, 2015
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC3 citations59
BIOELECTRON TECH CORP
4 patentsUS10189830B2Jan 29, 2019
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
BIOELECTRON TECH CORP3 citations71
US10071978B2Sep 11, 2018
Process for the production of alpha-tocotrienol and derivatives
BIOELECTRON TECH CORP3 citations67
US9868711B2Jan 16, 2018
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
BIOELECTRON TECH CORP0 citations39
US9670170B2Jun 6, 2017
Resorufin derivatives for treatment of oxidative stress disorders
BIOELECTRON TECH CORP0 citations39
HINMAN ANDREW W
3 patentsUS8716486B2May 6, 2014
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
HINMAN ANDREW W37 citations93
US8716527B2May 6, 2014
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
HINMAN ANDREW W35 citations92
US8952071B2Feb 10, 2015
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
HINMAN ANDREW W18 citations91